Mutually exclusive NRASQ61R and BRAFV600E mutations at the single-cell level in the same human melanoma
暂无分享,去创建一个
F. Lozupone | G. Nicolini | A. Anichini | D. Nonaka | G. Parmiani | S. Fais | A. Molla | C. Vegetti | I. Bersani | R. Mortarini | M. Sensi | R Mortarini | A Anichini | G Parmiani | M Sensi | S Fais | G Nicolini | C Petti | I Bersani | F Lozupone | A Molla | C Vegetti | D Nonaka | C. Petti
[1] A. Anichini,et al. N-RAS mutations and susceptibility to lymphokine-activated killer (LAK) cells in human melanoma , 1994, Melanoma research.
[2] J. Sebolt-Leopold,et al. Targeting the mitogen-activated protein kinase cascade to treat cancer , 2004, Nature Reviews Cancer.
[3] J. Downward. Use of RNA interference libraries to investigate oncogenic signalling in mammalian cells , 2004, Oncogene.
[4] J. Rak,et al. Oncogenes and tumor angiogenesis: the question of vascular "supply" and vascular "demand". , 2004, Seminars in cancer biology.
[5] Richard Marais,et al. The RAF proteins take centre stage , 2004, Nature Reviews Molecular Cell Biology.
[6] Channing J Der,et al. Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis? , 2004, Trends in cell biology.
[7] C. Pritchard,et al. Raf proteins and cancer: B-Raf is identified as a mutational target. , 2003, Biochimica et biophysica acta.
[8] J. Joyce,et al. Therapeutic Targeting of the Tumor Microenvironment. , 2021, Cancer discovery.
[9] M. Hendrix,et al. Remodeling of the Microenvironment by Aggressive Melanoma Tumor Cells , 2003, Annals of the New York Academy of Sciences.
[10] H. Kittler,et al. BRAF kinase gene V599E mutation in growing melanocytic lesions. , 2004, Journal of Investigative Dermatology.
[11] H. Moses,et al. Tumor-stroma interactions. , 2005, Current opinion in genetics & development.
[12] D. Bar-Sagi,et al. Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.
[13] S. Bézieau,et al. A ras-Mutated Peptide Targeted by CTL Infiltrating a Human Melanoma Lesion1 , 2002, The Journal of Immunology.
[14] Christopher J. Miller,et al. Method of mutation analysis may contribute to discrepancies in reports of (V599E)BRAF mutation frequencies in melanocytic neoplasms. , 2004, The Journal of investigative dermatology.
[15] M. Pierotti,et al. BRAF alterations are associated with complex mutational profiles in malignant melanoma , 2004, Oncogene.
[16] A. Nicholson,et al. Mutations of the BRAF gene in human cancer , 2002, Nature.
[17] R. Weinberg,et al. Ras modulates Myc activity to repress thrombospondin-1 expression and increase tumor angiogenesis. , 2003, Cancer cell.
[18] J. Durocher,et al. High Sensitivity Scanning of Colorectal Tumors and Matched Plasma DNA for Mutations in APC, TP53, K‐RAS, and BRAF Genes with a Novel DHPLC Fluorescence Detection Platform , 2004, Annals of the New York Academy of Sciences.
[19] M. Barbacid,et al. RAS oncogenes: the first 30 years , 2003, Nature Reviews Cancer.
[20] Åsa Sivertsson,et al. Pyrosequencing as an alternative to single-strand conformation polymorphism analysis for detection of N-ras mutations in human melanoma metastases. , 2002, Clinical chemistry.
[21] Mathew J Garnett,et al. Guilty as charged: B-RAF is a human oncogene. , 2004, Cancer cell.
[22] D. Schadendorf,et al. Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines. , 2005, Carcinogenesis.
[23] R. Marais,et al. The role of B-RAF in melanoma , 2005, Cancer and Metastasis Reviews.
[24] J. Shay,et al. BRAFE600-associated senescence-like cell cycle arrest of human naevi , 2005, Nature.
[25] Dirk Strumberg,et al. Phase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumors. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[26] Markus Ringnér,et al. Microarray expression profiling in melanoma reveals a BRAF mutation signature , 2004, Oncogene.
[27] J. Hoeffler,et al. Ras mutations in human melanoma: a marker of malignant progression. , 1994, The Journal of investigative dermatology.
[28] U. Ringborg,et al. N-ras mutations are common in melanomas from sun-exposed skin of humans but rare in mucosal membranes or unexposed skin. , 1998, The Journal of investigative dermatology.
[29] D. Barford,et al. Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF , 2004, Cell.
[30] F. Lozupone,et al. Effect Of Human Natural Killer and γδ T Cells on the Growth of Human Autologous Melanoma Xenografts in SCID Mice , 2004, Cancer Research.
[31] P. Meltzer,et al. High frequency of BRAF mutations in nevi , 2003, Nature Genetics.